Table 3.

Major clinical events during follow‐up

	Maximal‐tolerated‐dose group (n = 333)	Low‐dose group (n = 162)	P‐value
Death	3 (0.90)	3(1.85)	0.3317
Cardiovascular death	1 (0.30)	2 (1.23)	0.1929
Hospitalization	52 (15.62)	22(13.58)	0.9151
Recanalization	10 (3.00)	7 (4.32)	0.3590